Jacques Theze

This inventor holds 10 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Institut Pasteur, Diaccurate. Active years: 2001-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacques Theze. Retrieved from https://idiyas.com/inventor/jacques-theze

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 8)

% Patents Active = 30.0

EPO Patents = 1 (Patent Applications = 14)

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 45(Granted Patents)

Company Filing History:

Years Active: 2001-2022

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11365264 - Therapeutic methods and compositions (2022-06-21),

2. 11154587 - Use of peptides to stimulate the immune system (2021-10-26),

3. 10894035 - Use of indole compounds to stimulate the immune system (2021-01-19),

4. 7704490 - Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2 (2010-04-27),

5. 7662368 - Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2 (2010-02-16),

6. 7101965 - Peptides of IL-2 (2006-09-05),

7. 6929791 - Peptides of IL-2 and derivatives thereof (2005-08-16),

8. 6825334 - Peptides of IL-2 and derivatives thereof and their use as therapeutic agents (2004-11-30),

9. 6596853 - DNA encoding peptides of IL-2 (2003-07-22),

10. 6168785 - Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents (2001-01-02),

Title: Jacques Theze: Innovator in Immunology

Introduction

Jacques Theze is a prominent inventor based in Paris, France. He has made significant contributions to the field of immunology, holding a total of 10 patents. His work focuses on therapeutic methods and compositions aimed at diagnosing and treating immune disorders.

Latest Patents

Among his latest patents, Jacques has developed methods for diagnosing or treating immune disorders in subjects. These methods are based on the detection or modulation of Refractory State Inducing Factor (RIF). Additionally, he has created methods for treating immunodeficiencies using peptide-based compounds to stimulate the immune system.

Career Highlights

Throughout his career, Jacques has worked with esteemed organizations such as Institut Pasteur and Diaccurate. His innovative approaches have garnered attention in the scientific community, contributing to advancements in immunological therapies.

Collaborations

Jacques has collaborated with notable individuals in his field, including Ralph Eckenberg and Jean-Louis Moreau. Their combined expertise has furthered the development of groundbreaking therapeutic methods.

Conclusion

Jacques Theze's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the diagnosis and treatment of immune disorders, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.